Skip to main content
. 2019 Dec 30;8(12):2058460119894214. doi: 10.1177/2058460119894214

Table 1.

BAT and CV: differences between patients with MS and controls.

Patients with MS (n = 28) Controls (n = 19) P
BAT superior frontal gyrus 1290.8 (245.3–1403.2) 1321.9 (1283–1424.7) 0.43
BAT middle frontal gyrus 1401.6 (1301.6–1503.2) 1387.3 (1327.2–1448) 0.74
BAT inferior frontal gyrus 1210.6 (1166.8–1291.1) 1206.5 (1176.5–1304.4) 0.66
BAT caudate 1130.8 (1087.7–1201.3) 1155.3 (1113.9–1249.6) 0.15
BAT thalamus 1240.4 (1194.8–1311.9) 1264.5 (1203.9–1355.9) 0.26
CV superior frontal gyrus 22,993 (20,968.8–24,993) 21,983 (19,426–26,163) 0.91
CV middle frontal gyrus 22,378.5 (20,274.8–23,827) 23,014 (19,786–25,419) 0.39
CV inferior frontal gyrus 10,745 (10,072.2–11,732) 10,704 (9758–12,394) 0.7
CV caudate 3526.5 (3118.3–3922) 3307.4 (3060.7–3779.9) 0.32
CV thalamus 7601.5 (6813.5–8754.5) 8344.2 (7725.9–8854.1) 0.07

Values are given as median (IQR).

BAT, bolus arrival time (in ms); CV, cerebral volume (in mm3); EDSS: Expanded Disability Status Scale; IQR, interquartile range; MS, multiple sclerosis; SDMT: Symbol Digit Modalities Test.